stockrowPAVmed Inc.
PAVM Healthcare Medical Devices
PAVmed Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71,000.00, down 97.6% from fiscal 2024.
- Revenue
- +450.0%
- EPS
- +96.1%
- Free cash flow
- −125.6%
Quarter to June 2026, against a year earlier
Follow PAVM
Alert me
PAVmed Inc. (PAVM) EV/Sales
As of 6 November 2026, PAVmed Inc. (PAVM) trades at a EV/Sales of 189×. Over the past ten years it has ranged from −29.6× (December 2022) to 454× (July 2026); the current reading is higher than 92% of that period. That is above the Medical Devices industry median of 2.8× and above the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 109× | 3,875.81% |
| FY2024 | 2.7× | (30.03%) |
| FY2023 | 3.9× | 309.30% |
| FY2022 | 1.0× | — |
| FY2021 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 434× | 50.50% |
| Mar 2026 | 288× | 163.71% |
| Dec 2025 | 109× | (66.73%) |
| Sep 2025 | 328× | 3,184.64% |
| 15 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| MODD Modular Medical, Inc. compare | n/m |
| ITOC iTonic Holdings Ltd. compare | n/m |
| RBOT Vicarious Surgical Inc. compare | n/m |
| IRIX IRIDEX Corporation compare | 0.2× |
| BTCY Biotricity Inc. compare | 1.7× |
| SINT SINTX TECHNOLOGIES, INC. compare | 2.6× |
| PETV PetVivo Holdings, Inc. compare | 19.7× |
| PAVM PAVmed Inc. | 189× |
| HSCS HeartSciences Inc. compare | 519× |
| Medical Devices industry median | 2.8× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)